시장보고서

상품코드

1782021

세계의 저침습생검 기술 시장 : 제공 제품별, 기술별, 순환 바이오마커별, 용도별, 최종 사용자별, 국가별, 지역별 - 산업 분석, 시장 규모, 시장 점유율 예측(2025-2032년)

Minimally Invasive Biopsy Techniques Market, By Product Offered, By Technique, By Circulating Biomarker, By Application, By End User, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032

발행일: 2025년 07월 | 리서치사:

AnalystView Market Insights | 페이지 정보: 영문 393 Pages | 배송안내 : 2-3일 (영업일 기준)

샘플 요청 목록에 추가

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

보고서 하이라이트

세계의 저침습생검 기술 시장 규모는 2024년 131억 4,612만 달러로, 2025년부터 2032년까지 연평균 복합 성장률(CAGR) 10.5%로 확대될 것으로 예상

저침습생검 기술 시장 - 시장 역학

세계의 암 이환율 증가와 정밀진단의 중요성 증가가 시장 성장을 가속할 것으로 예측됩니다.

암의 이환율이 세계적으로 상승을 계속하는 가운데, 조기 한편 정밀하고, 침습성이 낮은 진단 방법이 급무가 되고 있습니다. 미세 바늘 흡입, 코어 바늘 생검, 액체 생검을 포함한 저침습생검 기술은 기존의 수술 접근법과 비교하여 회복 시간 단축, 환자 불편감 감소, 합병증 발생률 감소를 초래합니다. 세계보건기구(WHO)는 새로운 암 환자 수가 2050년까지 3,500만명에 달할 것으로 예측하고 있으며, 이는 2022년 기록된 2,000만명에서 77% 증가하는 것을 의미합니다. 그럼에도 불구하고, 종양학 연구, 맞춤형 의료, 건강 관리 혁신에 대한 투자가 증가하고 있다는 것은 시장 확대 기회를 초래할 수 있습니다. 또한 고급 생검 시스템과 관련된 높은 비용이 시장 성장을 방해할 수 있습니다.

저침습생검 기술 시장 - 주요 인사이트

조사 분석가의 분석에 따르면 세계 시장은 예측 기간(2025-2032년)에 약 10.5%의 연평균 복합 성장률(CAGR)로 매년 성장할 것으로 예측됩니다.

시장 세분화별로는 키트와 소모품이 2024년에 가장 큰 시장 점유율을 보여줄 것으로 예측됐습니다.

기술별로는 액체생검이 2024년 주요 기술이었습니다.

순환 바이오마커별로는 무세포 DNA(cfDNA)가 2024년 순환 바이오마커로서 리드했습니다.

용도별로는 임상이 2024년 주요 용도였습니다.

최종 사용자 세분화별로는 병원 및 클리닉이 2024년 주요 최종 사용자였습니다.

지역별로 북미는 2024년 주요 수익원이었습니다.

저침습생검 시장 - 세분화 분석 :

저침습생검 기술 시장은 제공 제품, 기술, 순환 바이오 마커, 용도, 최종 사용자, 지역에 따라 부문화됩니다.

시장은 제품별로 검사, 키트 및 소모품, 장비 부문으로 분할됩니다. 키트 및 소모품은 사용 빈도가 높고, 일회용이 가능하며, 무균이고 정확한 진단 절차를 보장하는 데 필수적인 기능을 갖추고 있기 때문에 시장에서 주도적인 역할을 수행합니다. 이 범주에는 생검 바늘, 집게, 주사기, 시약, 시료 채취 용기가 포함되며, 이들은 모두 미세침 흡입, 코어 생검, 진공 보조 생검을 포함한 다양한 생검 방법에 필수적입니다. 병원, 진단실험실 및 외래 환자에서 이러한 제품에 대한 지속적인 수요는 시장 점유율을 크게 밀어 올리고 있습니다.

시장은 기술별로 액체 생검, 광학 생검, 브러시 생검, 색소 병변 분석 등 4개의 부문으로 분류됩니다. 액체생검은 간단한 채혈로 암 관련 바이오마커를 확인할 수 있기 때문에 기존의 조직 생검보다 안전하고 신속하며 환자 중심 검사가 가능하며 시장 확대의 최전선에 있습니다. 이 검사는 침습적인 치료를 필요로 하지 않고 질병의 진행, 암의 조기 발견, 치료 효과의 평가를 실시간으로 모니터링하는 것을 용이하게 합니다. 정밀의료의 보급과 조기 암 진단에 대한 수요가 증가함에 따라 다양한 임상 환경에서 액체생검의 신속한 성장과 수용을 뒷받침하고 있습니다.

시장은 순환 바이오마커에 기초하여 순환 종양 세포(CTC), 무 세포 DNA(cfDNA), 순환 종양 DNA(ctDNA), 세포 외 소포 등 4개의 부문으로 분류됩니다. 무세포 DNA(cfDNA)는 시장 성장의 주요 촉진요인입니다. 액체생검 분야 중에서도 무세포 DNA(cfDNA)는 비침습적인 암 진단과 모니터링에 필수적인 기능이기 때문에 시장 확대의 최전선에 있습니다. 종양에서 혈류로 방출되는 DNA 단편을 분석함으로써 cfDNA는 유전자 변이, 종양 부하 및 치료 저항성의 확인을 용이하게 합니다. 수술적 개입을 필요로 하지 않고 실시간으로 종양의 동태를 파악할 수 있기 때문에 프레시젼 종양의 기본 요소로서 확립되어 있습니다.

시장은 용도에 따라 임상과 치료 두 가지 범주로 분류됩니다. 임상은 시장 성장의 주요 촉진요인입니다. 임상 응용은 저침습생검 기술 시장 확대의 최전선이며 표준 진단 및 질병 모니터링에서 이러한 절차의 채택이 증가하고 있음을 뒷받침하고 있습니다. 병원, 진단 실험실, 전문 클리닉은 특히 종양학 분야에서 조기 발견 및 맞춤형 치료 계획을 위해 액체생검, 미세 바늘 흡입, 영상 유도 생검 등 저침습 기술을 점차 채용하고 있습니다.

시장은 최종 사용자별로 병원 및 진료소, 학술기관 및 연구기관, 외래 의료센터의 3개로 구분됩니다. 병원 및 진료소는 저침습생검 기술 분야의 최종 사용자 중 시장 성장의 최전선에 있으며, 그 이유는 환자 수가 많음, 진보된 진단 시설의 존재, 의료 전문가의 전문 지식에 있습니다. 이러한 환경은 특히 종양학에서 미세 바늘 흡입, 코어 니들 생검, 액체 생검과 같은 절차가 일반적으로 수행되는 질병 발견을 위한 1차 치료 지점으로 작용합니다. 학술연구기관도 중요한 역할을 하고 있으며, 혁신적인 생검법의 개발과 바이오마커의 발견에 힘을 쏟고 있습니다. 대조적으로, 외래 진료 센터에서는 외래에서 비용 효율적이고 회복이 빠르고 침습성이 낮은 절차를 선호하는 경향이 강해져 도입이 증가하고 있습니다.

저침습생검 기술 시장 - 지리적 통찰

북미는 주로 액체생검 채용 증가로 시장 성장을 이끌고 있습니다. 암 이환율의 상승에 더해, 조기 한편 정확한 진단에의 강한 관심이, 리퀴드 생검의 임상에의 도입을 촉진하고 있습니다. 또한 유명한 생명 공학 기업의 존재, 정교한 건강 관리 인프라 및 지원 규제 프레임 워크가 시장 성장을 더욱 강화하고 있습니다. 인구 3억 3,000만 명이 넘는 미국은 의료 제공업체, 지불자, 의료를 받는 환자의 상호관계를 특징으로 하는 세계에서 가장 복잡한 헬스케어 시스템의 혜택을 받고 있습니다. 유럽은 이미징과 네비게이션 기술의 발전으로 시장 성장률 2위를 차지하고 있습니다.

저침습생검 시장 - 경쟁 구도 :

저침습생검 시장의 경쟁 환경은 다양한 기존 의료기기 제조업체, 진단 기업 및 신흥 바이오 벤처 기업의 진입을 특징으로합니다. 주요 기업은 정확성을 높이고 절차 위험을 줄이기 위해 고안된 고급 이미지 유도, 로봇 지원, AI 통합 생검 솔루션을 개발하고 있습니다. 특히 순환종양 DNA(ctDNA)와 무세포 DNA(cfDNA)에 초점을 맞춘 비침습적 액체생검 기술에 투자해 실시간으로 암 모니터링을 가능하게 하고 있습니다. 게다가 기업은 보다 침습적인 진단 접근법에 대한 수요 증가에 대응하기 위해 아시아태평양 및 라틴아메리카에서 사업을 확대하고 있습니다.

소개
북미
- 개요
- 북미의 주요 제조업체
- 미국
- 캐나다
유럽
- 개요
- 유럽의 주요 제조업체
- 독일
- 영국
- 프랑스
- 이탈리아
- 스페인
- 네덜란드
- 스웨덴
- 러시아
- 폴란드
- 기타
아시아태평양(APAC)
- 개요
- 아시아태평양의 주요 제조업체
- 중국
- 인도
- 일본
- 한국
- 호주
- 인도네시아
- 태국
- 필리핀
- 기타
라틴아메리카(LATAM)
- 개요
- 라틴아메리카의 주요 제조업체
- 브라질
- 멕시코
- 아르헨티나
- 콜롬비아
- 기타
중동 및 아프리카
- 개요
- 중동 및 아프리카의 주요 제조업체
- 사우디아라비아
- 아랍에미리트(UAE)
- 이스라엘
- 튀르키예
- 알제리
- 이집트
- 기타

제13장 주요 벤더 분석 - 저침습생검 기술 업계

경쟁 대시보드
- 경쟁 벤치마킹
- 경쟁 포지셔닝
기업 프로파일
- Becton, Dickinson and Company(BD)
- Danaher Corporation(Leica Biosystems)
- Hologic, Inc.
- Boston Scientific Corporation
- Medtronic plc
- Siemens Healthineers
- GE HealthCare
- Philips Healthcare
- Argon Medical Devices
- Cook Medical
- Fujifilm Holdings Corporation
- Olympus Corporation
- R. Bard(now part of BD)
- Biocept, Inc.
- Guardant Health
- Qiagen NV
- Exact Sciences Corporation
- Bio-Rad Laboratories
- Menarini Silicon Biosystems
- NeoGenomics Laboratories
- Others

제14장 애널리스트의 전방위 전망

JHS 25.08.11

REPORT HIGHLIGHT

Minimally Invasive Biopsy Techniques Market size was valued at US$ 13,146.12 Million in 2024, expanding at a CAGR of 10.5% from 2025 to 2032.

Minimally invasive biopsy techniques refer to procedures that obtain tissue samples for diagnostic purposes through smaller incisions and with less damage to surrounding tissue than traditional surgical biopsies. These methods present benefits such as diminished scarring, quicker recovery times, and a lower likelihood of complications. Frequently utilized techniques include fine-needle aspiration (FNA), core needle biopsy (CNB), and vacuum-assisted biopsy (VAB), which are often performed with the assistance of imaging technologies such as ultrasound, MRI, or mammography. Overall, minimally invasive biopsy techniques represent a significant advancement in tissue sampling, delivering precise diagnoses while minimizing the burden on patients.

Minimally Invasive Biopsy Techniques Market- Market Dynamics

The increasing global prevalence of cancer, along with the growing significance of precision diagnostics, is anticipated to propel market growth.

As the incidence of cancer continues to rise globally, there is an urgent requirement for early, precise, and less invasive diagnostic methods. Minimally invasive biopsy techniques, including fine-needle aspiration, core needle biopsy, and liquid biopsy, provide quicker recovery times, decreased patient discomfort, and lower rates of complications when compared to conventional surgical approaches. The World Health Organization estimates that the number of new cancer cases is expected to reach 35 million by 2050, which signifies a 77% increase from the 20 million cases documented in 2022. Nevertheless, increasing investments in oncology research, personalized medicine, and healthcare innovation may present opportunities for market expansion. Furthermore, the high costs associated with advanced biopsy systems could hinder market growth.

Minimally Invasive Biopsy Techniques Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 10.5% over the forecast period (2025-2032)

Based on Product Offered segmentation, Kits & Consumables were predicted to show the maximum market share in the year 2024

Based on Technique segmentation, Liquid Biopsy was the leading Technique in 2024

Based on Circulating Biomarker segmentation, cell-free DNA (cfDNA) was the leading Circulating Biomarker in 2024

Based on Application segmentation, Clinical was the leading Application in 2024

Based on end-user segmentation, Hospitals and clinics were the leading end users in 2024

Based on region, North America was the leading revenue generator in 2024

Minimally Invasive Biopsy Techniques Market- Segmentation Analysis:

The Global Minimally Invasive Biopsy Techniques Market is segmented based on Product Offered, Technique, Circulating Biomarker, Application, End User, and Region.

The market is divided into three segments according to the Products Offered: Tests, Kits & Consumables, and Instruments. Kits & Consumables occupy a leading role in the market, attributed to their frequent usage, disposability, and essential function in ensuring sterile and accurate diagnostic procedures. This category encompasses biopsy needles, forceps, syringes, reagents, and sample collection containers, all of which are vital for various biopsy methods, including fine-needle aspiration, core needle biopsy, and vacuum-assisted biopsy. The ongoing demand for these products in hospitals, diagnostic laboratories, and outpatient settings significantly boosts their substantial market share.

The market is categorized into four segments based on Technique: Liquid Biopsy, Optical Biopsy, Brush Biopsy, Pigmented Lesion Assays, and Others. Liquid Biopsy is at the forefront of market expansion, owing to its capability to identify cancer-related biomarkers through a straightforward blood draw, providing a safer, quicker, and more patient-centric alternative to conventional tissue biopsies. It facilitates real-time monitoring of disease progression, early cancer detection, and evaluation of treatment responses without requiring invasive procedures. The growing adoption of precision medicine and the increasing demand for early cancer diagnostics are propelling the swift growth and acceptance of liquid biopsy in various clinical environments.

The market is categorized into four segments based on circulating Biomarkers: Circulating Tumor Cells (CTCs), Cell-Free DNA (cfDNA), Circulating Tumor DNA (ctDNA), Extracellular Vesicles, and Others. Cell-Free DNA (cfDNA) is the primary driver of market growth. Within the liquid biopsy sector, cell-free DNA (cfDNA) is at the forefront of market expansion due to its essential function in non-invasive cancer diagnostics and monitoring. By analyzing fragments of DNA released by tumors into the bloodstream, cfDNA facilitates the identification of genetic mutations, tumor burden, and treatment resistance. Its capacity to deliver real-time insights into tumor dynamics without requiring surgical interventions has established it as a fundamental element in precision oncology.

The market is segmented into two categories according to Application: Clinical and Therapeutic. Clinical is the primary driver of market growth. Clinical applications are at the forefront of market expansion in minimally invasive biopsy techniques, propelled by the rising adoption of these procedures in standard diagnostics and disease monitoring. Hospitals, diagnostic laboratories, and specialty clinics are progressively employing minimally invasive techniques such as liquid biopsy, fine-needle aspiration, and image-guided biopsies for early detection and tailored treatment planning, especially in the field of oncology.

The market is segmented into three categories based on End-User: Hospitals & Clinics, Academic & Research Institutions, and Ambulatory Care Centers. Hospitals and clinics are at the forefront of market growth among end users in the minimally invasive biopsy techniques sector, attributed to the high patient volume, the presence of advanced diagnostic facilities, and the expertise of medical professionals. These environments serve as the primary point of care for disease detection, particularly in oncology, where procedures such as fine-needle aspiration, core needle biopsy, and liquid biopsy are commonly conducted. Academic and research institutions also play a vital role, concentrating on the advancement of innovative biopsy methods and the discovery of biomarkers. In contrast, ambulatory care centers are witnessing an increase in adoption due to the growing preference for outpatient, cost-effective, and minimally invasive procedures that offer faster recovery times.

Minimally Invasive Biopsy Techniques Market- Geographical Insights

North America leads in market growth, primarily due to the increasing adoption of liquid biopsy. The rising incidence of cancer, along with a strong focus on early and accurate diagnosis, has expedited the incorporation of liquid biopsy into clinical practices. Furthermore, the presence of prominent biotechnology firms, sophisticated healthcare infrastructure, and supportive regulatory frameworks has further propelled market growth. The United States (US), with a population exceeding 330 million, benefits from one of the most intricate healthcare systems globally, characterized by the interconnected relationships among providers, payers, and patients receiving care. Europe ranks as the second largest region for market growth, attributed to advancements in imaging and navigation technologies.

Minimally Invasive Biopsy Techniques Market- Competitive Landscape:

The competitive environment of the Minimally Invasive Biopsy Techniques Market is characterized by the participation of various established medical device manufacturers, diagnostic firms, and emerging biotech startups. Leading companies are developing advanced imaging-guided, robotic-assisted, and AI-integrated biopsy solutions designed to enhance accuracy and reduce procedural risks. Organizations are investing in non-invasive liquid biopsy technologies, especially those focusing on circulating tumor DNA (ctDNA) and cell-free DNA (cfDNA), to enable real-time cancer monitoring. Furthermore, companies are broadening their operations in the Asia-Pacific and Latin America regions to take advantage of the growing demand for less invasive diagnostic approaches.

Recent Developments:

On January 22, 2025, GRACE Breast Imaging & Medical Spa of Iowa, located in Urbandale and Clive, achieved a significant milestone by becoming the first healthcare facility in the United States to install the innovative Mammomat B.brilliant. This marks the first complete redesign of a mammography platform by Siemens Healthineers in over ten years. The Mammomat B.brilliant incorporates advanced 3D image acquisition and image reconstruction technology, along with capabilities for full-field digital mammography, which includes two-dimensional breast imaging, breast biopsy, and titanium contrast-enhanced mammography.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL MINIMALLY INVASIVE BIOPSY TECHNIQUES MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

Becton, Dickinson and Company (BD)
Danaher Corporation (Leica Biosystems)
Hologic, Inc.
Boston Scientific Corporation
Medtronic plc
Siemens Healthineers
GE HealthCare
Philips Healthcare
Argon Medical Devices
Cook Medical
Fujifilm Holdings Corporation
Olympus Corporation
R. Bard (now part of BD)
Biocept, Inc.
Guardant Health
Qiagen N.V.
Exact Sciences Corporation
Bio-Rad Laboratories
Menarini Silicon Biosystems
NeoGenomics Laboratories
Others

GLOBAL MINIMALLY INVASIVE BIOPSY TECHNIQUES MARKET, BY PRODUCT OFFERED- MARKET ANALYSIS, 2019 - 2032

Tests
Kits & Consumables
Instruments

GLOBAL MINIMALLY INVASIVE BIOPSY TECHNIQUES MARKET, BY TECHNIQUE- MARKET ANALYSIS, 2019 - 2032

Liquid Biopsy
Optical Biopsy
Brush Biopsy
Pigmented Lesion Assays
Others

GLOBAL MINIMALLY INVASIVE BIOPSY TECHNIQUES MARKET, BY CIRCULATING BIOMAKER- MARKET ANALYSIS, 2019 - 2032

Circulating Tumor Cells (CTCs)
Cell Free DNA (cfDNA)
Circulating Tumor DNA (ctDNA)
Extracellular Vesicles
Others

GLOBAL MINIMALLY INVASIVE BIOPSY TECHNIQUES MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

Clinical
Treatment Monitoring
Prognosis & Recurrence Monitoring
Treatment Selection
Others
Therapeutic
Lung Cancer
Breast Cancer
Prostate Cancer
Colorectal Cancer
Others

GLOBAL MINIMALLY INVASIVE BIOPSY TECHNIQUES MARKET, BY END USER- MARKET ANALYSIS, 2019 - 2032

Hospitals & Clinics
Academic & Research Institutions
Ambulatory Care Centers

GLOBAL MINIMALLY INVASIVE BIOPSY TECHNIQUES MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

North America
U.S.
Canada
Europe
Germany
UK
France
Italy
Spain
The Netherlands
Sweden
Russia
Poland
Rest of Europe
Asia Pacific
China
India
Japan
South Korea
Australia
Indonesia
Thailand
Philippines
Rest of APAC
Latin America
Brazil
Mexico
Argentina
Colombia
Rest of LATAM
The Middle East and Africa
Saudi Arabia
UAE
Israel
Turkey
Algeria
Egypt
Rest of MEA

1. Minimally Invasive Biopsy Techniques Market Overview

1.1. Study Scope
1.2. Market Estimation Years

2. Executive Summary

2.1. Market Snippet
- 2.1.1. Minimally Invasive Biopsy Techniques Market Snippet by Product Offered
- 2.1.2. Minimally Invasive Biopsy Techniques Market Snippet by Technique
- 2.1.3. Minimally Invasive Biopsy Techniques Market Snippet by Circulating Biomaker
- 2.1.4. Minimally Invasive Biopsy Techniques Market Snippet by Application
- 2.1.5. Minimally Invasive Biopsy Techniques Market Snippet by End User
- 2.1.6. Minimally Invasive Biopsy Techniques Market Snippet by Country
- 2.1.7. Minimally Invasive Biopsy Techniques Market Snippet by Region
2.2. Competitive Insights

3. Minimally Invasive Biopsy Techniques Key Market Trends

3.1. Minimally Invasive Biopsy Techniques Market Drivers
- 3.1.1. Impact Analysis of Market Drivers
3.2. Minimally Invasive Biopsy Techniques Market Restraints
- 3.2.1. Impact Analysis of Market Restraints
3.3. Minimally Invasive Biopsy Techniques Market Opportunities
3.4. Minimally Invasive Biopsy Techniques Market Future Trends

4. Minimally Invasive Biopsy Techniques Industry Study

4.1. PEST Analysis
4.2. Porter's Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis

5. Minimally Invasive Biopsy Techniques Market: Impact of Escalating Geopolitical Tensions

5.1. Impact of COVID-19 Pandemic
5.2. Impact of Russia-Ukraine War
5.3. Impact of Middle East Conflicts

6. Minimally Invasive Biopsy Techniques Market Landscape

6.1. Minimally Invasive Biopsy Techniques Market Share Analysis, 2024
6.2. Breakdown Data, by Key Manufacturer
- 6.2.1. Established Players' Analysis
- 6.2.2. Emerging Players' Analysis

7. Minimally Invasive Biopsy Techniques Market - By Product Offered

7.1. Overview
- 7.1.1. Segment Share Analysis, By Product Offered, 2024 & 2032 (%)
- 7.1.2. Tests
- 7.1.3. Kits & Consumables
- 7.1.4. Instruments

8. Minimally Invasive Biopsy Techniques Market - By Technique

8.1. Overview
- 8.1.1. Segment Share Analysis, By Technique, 2024 & 2032 (%)
- 8.1.2. Liquid Biopsy
- 8.1.3. Optical Biopsy
- 8.1.4. Brush Biopsy
- 8.1.5. Pigmented Lesion Assays
- 8.1.6. Others

9. Minimally Invasive Biopsy Techniques Market - By Circulating Biomaker

9.1. Overview
- 9.1.1. Segment Share Analysis, By Circulating Biomaker, 2024 & 2032 (%)
- 9.1.2. Circulating Tumor Cells (CTCs)
- 9.1.3. Cell Free DNA (cfDNA)
- 9.1.4. Circulating Tumor DNA (ctDNA)
- 9.1.5. Extracellular Vesicles
- 9.1.6. Others

10. Minimally Invasive Biopsy Techniques Market - By Application

10.1. Overview
- 10.1.1. Segment Share Analysis, By Application, 2024 & 2032 (%)
- 10.1.2. Clinical
  - 10.1.2.1. Treatment Monitoring
  - 10.1.2.2. Prognosis & Recurrence Monitoring
  - 10.1.2.3. Treatment Selection
  - 10.1.2.4. Others
- 10.1.3. Therapeutic
  - 10.1.3.1. Lung Cancer
  - 10.1.3.2. Breast Cancer
  - 10.1.3.3. Prostate Cancer
  - 10.1.3.4. Colorectal Cancer
  - 10.1.3.5. Others

11. Minimally Invasive Biopsy Techniques Market - By End User

11.1. Overview
- 11.1.1. Segment Share Analysis, By End User, 2024 & 2032 (%)
- 11.1.2. Hospitals & Clinics
- 11.1.3. Academic & Research Institutions
- 11.1.4. Ambulatory Care Centers

12. Minimally Invasive Biopsy Techniques Market- By Geography

12.1. Introduction
- 12.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
12.2. North America
- 12.2.1. Overview
- 12.2.2. Minimally Invasive Biopsy Techniques Key Manufacturers in North America
- 12.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 12.2.4. North America Market Size and Forecast, By Product Offered, 2019 - 2032 (US$ Million)
- 12.2.5. North America Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
- 12.2.6. North America Market Size and Forecast, By Circulating Biomaker, 2019 - 2032 (US$ Million)
- 12.2.7. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 12.2.8. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.2.9. U.S.
  - 12.2.9.1. Overview
  - 12.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.2.9.3. U.S. Market Size and Forecast, By Product Offered, 2019 - 2032 (US$ Million)
  - 12.2.9.4. U.S. Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
  - 12.2.9.5. U.S. Market Size and Forecast, By Circulating Biomaker, 2019 - 2032 (US$ Million)
  - 12.2.9.6. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.2.9.7. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.2.10. Canada
  - 12.2.10.1. Overview
  - 12.2.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.2.10.3. Canada Market Size and Forecast, By Product Offered, 2019 - 2032 (US$ Million)
  - 12.2.10.4. Canada Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
  - 12.2.10.5. Canada Market Size and Forecast, By Circulating Biomaker, 2019 - 2032 (US$ Million)
  - 12.2.10.6. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.2.10.7. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3. Europe
- 12.3.1. Overview
- 12.3.2. Minimally Invasive Biopsy Techniques Key Manufacturers in Europe
- 12.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 12.3.4. Europe Market Size and Forecast, By Product Offered, 2019 - 2032 (US$ Million)
- 12.3.5. Europe Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
- 12.3.6. Europe Market Size and Forecast, By Circulating Biomaker, 2019 - 2032 (US$ Million)
- 12.3.7. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 12.3.8. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.3.9. Germany
  - 12.3.9.1. Overview
  - 12.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.3.9.3. Germany Market Size and Forecast, By Product Offered, 2019 - 2032 (US$ Million)
  - 12.3.9.4. Germany Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
  - 12.3.9.5. Germany Market Size and Forecast, By Circulating Biomaker, 2019 - 2032 (US$ Million)
  - 12.3.9.6. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.3.9.7. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.3.10. UK
  - 12.3.10.1. Overview
  - 12.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.3.10.3. UK Market Size and Forecast, By Product Offered, 2019 - 2032 (US$ Million)
  - 12.3.10.4. UK Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
  - 12.3.10.5. UK Market Size and Forecast, By Circulating Biomaker, 2019 - 2032 (US$ Million)
  - 12.3.10.6. UK Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.3.10.7. UK Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.3.11. France
  - 12.3.11.1. Overview
  - 12.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.3.11.3. France Market Size and Forecast, By Product Offered, 2019 - 2032 (US$ Million)
  - 12.3.11.4. France Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
  - 12.3.11.5. France Market Size and Forecast, By Circulating Biomaker, 2019 - 2032 (US$ Million)
  - 12.3.11.6. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.3.11.7. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.3.12. Italy
  - 12.3.12.1. Overview
  - 12.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.3.12.3. Italy Market Size and Forecast, By Product Offered, 2019 - 2032 (US$ Million)
  - 12.3.12.4. Italy Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
  - 12.3.12.5. Italy Market Size and Forecast, By Circulating Biomaker, 2019 - 2032 (US$ Million)
  - 12.3.12.6. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.3.12.7. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.3.13. Spain
  - 12.3.13.1. Overview
  - 12.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.3.13.3. Spain Market Size and Forecast, By Product Offered, 2019 - 2032 (US$ Million)
  - 12.3.13.4. Spain Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
  - 12.3.13.5. Spain Market Size and Forecast, By Circulating Biomaker, 2019 - 2032 (US$ Million)
  - 12.3.13.6. Spain Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.3.13.7. Spain Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.3.14. The Netherlands
  - 12.3.14.1. Overview
  - 12.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.3.14.3. The Netherlands Market Size and Forecast, By Product Offered, 2019 - 2032 (US$ Million)
  - 12.3.14.4. The Netherlands Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
  - 12.3.14.5. The Netherlands Market Size and Forecast, By Circulating Biomaker, 2019 - 2032 (US$ Million)
  - 12.3.14.6. The Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.3.14.7. The Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.3.15. Sweden
  - 12.3.15.1. Overview
  - 12.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.3.15.3. Sweden Market Size and Forecast, By Product Offered, 2019 - 2032 (US$ Million)
  - 12.3.15.4. Sweden Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
  - 12.3.15.5. Sweden Market Size and Forecast, By Circulating Biomaker, 2019 - 2032 (US$ Million)
  - 12.3.15.6. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.3.15.7. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.3.16. Russia
  - 12.3.16.1. Overview
  - 12.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.3.16.3. Russia Market Size and Forecast, By Product Offered, 2019 - 2032 (US$ Million)
  - 12.3.16.4. Russia Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
  - 12.3.16.5. Russia Market Size and Forecast, By Circulating Biomaker, 2019 - 2032 (US$ Million)
  - 12.3.16.6. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.3.16.7. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.3.17. Poland
  - 12.3.17.1. Overview
  - 12.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.3.17.3. Poland Market Size and Forecast, By Product Offered, 2019 - 2032 (US$ Million)
  - 12.3.17.4. Poland Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
  - 12.3.17.5. Poland Market Size and Forecast, By Circulating Biomaker, 2019 - 2032 (US$ Million)
  - 12.3.17.6. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.3.17.7. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.3.18. Rest of Europe
  - 12.3.18.1. Overview
  - 12.3.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.3.18.3. Rest of the Europe Market Size and Forecast, By Product Offered, 2019 - 2032 (US$ Million)
  - 12.3.18.4. Rest of the Europe Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
  - 12.3.18.5. Rest of the Europe Market Size and Forecast, By Circulating Biomaker, 2019 - 2032 (US$ Million)
  - 12.3.18.6. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.3.18.7. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.4. Asia Pacific (APAC)
- 12.4.1. Overview
- 12.4.2. Minimally Invasive Biopsy Techniques Key Manufacturers in Asia Pacific
- 12.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 12.4.4. APAC Market Size and Forecast, By Product Offered, 2019 - 2032 (US$ Million)
- 12.4.5. APAC Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
- 12.4.6. APAC Market Size and Forecast, By Circulating Biomaker, 2019 - 2032 (US$ Million)
- 12.4.7. APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 12.4.8. APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.4.9. China
  - 12.4.9.1. Overview
  - 12.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.4.9.3. China Market Size and Forecast, By Product Offered, 2019 - 2032 (US$ Million)
  - 12.4.9.4. China Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
  - 12.4.9.5. China Market Size and Forecast, By Circulating Biomaker, 2019 - 2032 (US$ Million)
  - 12.4.9.6. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.4.9.7. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.4.10. India
  - 12.4.10.1. Overview
  - 12.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.4.10.3. India Market Size and Forecast, By Product Offered, 2019 - 2032 (US$ Million)
  - 12.4.10.4. India Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
  - 12.4.10.5. India Market Size and Forecast, By Circulating Biomaker, 2019 - 2032 (US$ Million)
  - 12.4.10.6. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.4.10.7. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.4.11. Japan
  - 12.4.11.1. Overview
  - 12.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.4.11.3. Japan Market Size and Forecast, By Product Offered, 2019 - 2032 (US$ Million)
  - 12.4.11.4. Japan Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
  - 12.4.11.5. Japan Market Size and Forecast, By Circulating Biomaker, 2019 - 2032 (US$ Million)
  - 12.4.11.6. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.4.11.7. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.4.12. South Korea
  - 12.4.12.1. Overview
  - 12.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.4.12.3. South Korea Market Size and Forecast, By Product Offered, 2019 - 2032 (US$ Million)
  - 12.4.12.4. South Korea Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
  - 12.4.12.5. South Korea Market Size and Forecast, By Circulating Biomaker, 2019 - 2032 (US$ Million)
  - 12.4.12.6. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.4.12.7. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.4.13. Australia
  - 12.4.13.1. Overview
  - 12.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.4.13.3. Australia Market Size and Forecast, By Product Offered, 2019 - 2032 (US$ Million)
  - 12.4.13.4. Australia Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
  - 12.4.13.5. Australia Market Size and Forecast, By Circulating Biomaker, 2019 - 2032 (US$ Million)
  - 12.4.13.6. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.4.13.7. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.4.14. Indonesia
  - 12.4.14.1. Overview
  - 12.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.4.14.3. Indonesia Market Size and Forecast, By Product Offered, 2019 - 2032 (US$ Million)
  - 12.4.14.4. Indonesia Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
  - 12.4.14.5. Indonesia Market Size and Forecast, By Circulating Biomaker, 2019 - 2032 (US$ Million)
  - 12.4.14.6. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.4.14.7. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.4.15. Thailand
  - 12.4.15.1. Overview
  - 12.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.4.15.3. Thailand Market Size and Forecast, By Product Offered, 2019 - 2032 (US$ Million)
  - 12.4.15.4. Thailand Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
  - 12.4.15.5. Thailand Market Size and Forecast, By Circulating Biomaker, 2019 - 2032 (US$ Million)
  - 12.4.15.6. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.4.15.7. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.4.16. Philippines
  - 12.4.16.1. Overview
  - 12.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.4.16.3. Philippines Market Size and Forecast, By Product Offered, 2019 - 2032 (US$ Million)
  - 12.4.16.4. Philippines Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
  - 12.4.16.5. Philippines Market Size and Forecast, By Circulating Biomaker, 2019 - 2032 (US$ Million)
  - 12.4.16.6. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.4.16.7. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.4.17. Rest of APAC
  - 12.4.17.1. Overview
  - 12.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.4.17.3. Rest of APAC Market Size and Forecast, By Product Offered, 2019 - 2032 (US$ Million)
  - 12.4.17.4. Rest of APAC Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
  - 12.4.17.5. Rest of APAC Market Size and Forecast, By Circulating Biomaker, 2019 - 2032 (US$ Million)
  - 12.4.17.6. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.4.17.7. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.5. Latin America (LATAM)
- 12.5.1. Overview
- 12.5.2. Minimally Invasive Biopsy Techniques Key Manufacturers in Latin America
- 12.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 12.5.4. LATAM Market Size and Forecast, By Product Offered, 2019 - 2032 (US$ Million)
- 12.5.5. LATAM Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
- 12.5.6. LATAM Market Size and Forecast, By Circulating Biomaker, 2019 - 2032 (US$ Million)
- 12.5.7. LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 12.5.8. LATAM Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.5.9. Brazil
  - 12.5.9.1. Overview
  - 12.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.5.9.3. Brazil Market Size and Forecast, By Product Offered, 2019 - 2032 (US$ Million)
  - 12.5.9.4. Brazil Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
  - 12.5.9.5. Brazil Market Size and Forecast, By Circulating Biomaker, 2019 - 2032 (US$ Million)
  - 12.5.9.6. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.5.9.7. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.5.10. Mexico
  - 12.5.10.1. Overview
  - 12.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.5.10.3. Mexico Market Size and Forecast, By Product Offered, 2019 - 2032 (US$ Million)
  - 12.5.10.4. Mexico Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
  - 12.5.10.5. Mexico Market Size and Forecast, By Circulating Biomaker, 2019 - 2032 (US$ Million)
  - 12.5.10.6. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.5.10.7. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.5.11. Argentina
  - 12.5.11.1. Overview
  - 12.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.5.11.3. Argentina Market Size and Forecast, By Product Offered, 2019 - 2032 (US$ Million)
  - 12.5.11.4. Argentina Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
  - 12.5.11.5. Argentina Market Size and Forecast, By Circulating Biomaker, 2019 - 2032 (US$ Million)
  - 12.5.11.6. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.5.11.7. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.5.12. Colombia
  - 12.5.12.1. Overview
  - 12.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.5.12.3. Colombia Market Size and Forecast, By Product Offered, 2019 - 2032 (US$ Million)
  - 12.5.12.4. Colombia Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
  - 12.5.12.5. Colombia Market Size and Forecast, By Circulating Biomaker, 2019 - 2032 (US$ Million)
  - 12.5.12.6. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.5.12.7. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.5.13. Rest of LATAM
  - 12.5.13.1. Overview
  - 12.5.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.5.13.3. Rest of LATAM Market Size and Forecast, By Product Offered, 2019 - 2032 (US$ Million)
  - 12.5.13.4. Rest of LATAM Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
  - 12.5.13.5. Rest of LATAM Market Size and Forecast, By Circulating Biomaker, 2019 - 2032 (US$ Million)
  - 12.5.13.6. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.5.13.7. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.6. Middle East and Africa
- 12.6.1. Overview
- 12.6.2. Minimally Invasive Biopsy Techniques Key Manufacturers in Middle East and Africa
- 12.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 12.6.4. Middle East and Africa Market Size and Forecast, By Product Offered, 2019 - 2032 (US$ Million)
- 12.6.5. Middle East and Africa Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
- 12.6.6. Middle East and Africa Market Size and Forecast, By Circulating Biomaker, 2019 - 2032 (US$ Million)
- 12.6.7. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 12.6.8. Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.6.9. Saudi Arabia
  - 12.6.9.1. Overview
  - 12.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.6.9.3. Saudi Arabia Market Size and Forecast, By Product Offered, 2019 - 2032 (US$ Million)
  - 12.6.9.4. Saudi Arabia Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
  - 12.6.9.5. Saudi Arabia Market Size and Forecast, By Circulating Biomaker, 2019 - 2032 (US$ Million)
  - 12.6.9.6. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.6.9.7. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.6.10. United Arab Emirates
  - 12.6.10.1. Overview
  - 12.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.6.10.3. United Arab Emirates Market Size and Forecast, By Product Offered, 2019 - 2032 (US$ Million)
  - 12.6.10.4. United Arab Emirates Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
  - 12.6.10.5. United Arab Emirates Market Size and Forecast, By Circulating Biomaker, 2019 - 2032 (US$ Million)
  - 12.6.10.6. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.6.10.7. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.6.11. Israel
  - 12.6.11.1. Overview
  - 12.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.6.11.3. Israel Market Size and Forecast, By Product Offered, 2019 - 2032 (US$ Million)
  - 12.6.11.4. Israel Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
  - 12.6.11.5. Israel Market Size and Forecast, By Circulating Biomaker, 2019 - 2032 (US$ Million)
  - 12.6.11.6. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.6.11.7. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.6.12. Turkey
  - 12.6.12.1. Overview
  - 12.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.6.12.3. Turkey Market Size and Forecast, By Product Offered, 2019 - 2032 (US$ Million)
  - 12.6.12.4. Turkey Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
  - 12.6.12.5. Turkey Market Size and Forecast, By Circulating Biomaker, 2019 - 2032 (US$ Million)
  - 12.6.12.6. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.6.12.7. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.6.13. Algeria
  - 12.6.13.1. Overview
  - 12.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.6.13.3. Algeria Market Size and Forecast, By Product Offered, 2019 - 2032 (US$ Million)
  - 12.6.13.4. Algeria Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
  - 12.6.13.5. Algeria Market Size and Forecast, By Circulating Biomaker, 2019 - 2032 (US$ Million)
  - 12.6.13.6. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.6.13.7. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.6.14. Egypt
  - 12.6.14.1. Overview
  - 12.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.6.14.3. Egypt Market Size and Forecast, By Product Offered, 2019 - 2032 (US$ Million)
  - 12.6.14.4. Egypt Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
  - 12.6.14.5. Egypt Market Size and Forecast, By Circulating Biomaker, 2019 - 2032 (US$ Million)
  - 12.6.14.6. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.6.14.7. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.6.15. Rest of MEA
  - 12.6.15.1. Overview
  - 12.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.6.15.3. Rest of MEA Market Size and Forecast, By Product Offered, 2019 - 2032 (US$ Million)
  - 12.6.15.4. Rest of MEA Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
  - 12.6.15.5. Rest of MEA Market Size and Forecast, By Circulating Biomaker, 2019 - 2032 (US$ Million)
  - 12.6.15.6. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.6.15.7. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)

13. Key Vendor Analysis- Minimally Invasive Biopsy Techniques Industry

13.1. Competitive Dashboard
- 13.1.1. Competitive Benchmarking
- 13.1.2. Competitive Positioning
13.2. Company Profiles
- 13.2.1. Becton, Dickinson and Company (BD)
- 13.2.2. Danaher Corporation (Leica Biosystems)
- 13.2.3. Hologic, Inc.
- 13.2.4. Boston Scientific Corporation
- 13.2.5. Medtronic plc
- 13.2.6. Siemens Healthineers
- 13.2.7. GE HealthCare
- 13.2.8. Philips Healthcare
- 13.2.9. Argon Medical Devices
- 13.2.10. Cook Medical
- 13.2.11. Fujifilm Holdings Corporation
- 13.2.12. Olympus Corporation
- 13.2.13. R. Bard (now part of BD)
- 13.2.14. Biocept, Inc.
- 13.2.15. Guardant Health
- 13.2.16. Qiagen N.V.
- 13.2.17. Exact Sciences Corporation
- 13.2.18. Bio-Rad Laboratories
- 13.2.19. Menarini Silicon Biosystems
- 13.2.20. NeoGenomics Laboratories
- 13.2.21. Others

14. 360 Degree Analyst View

15. Appendix

15.1. Research Methodology
15.2. References
15.3. Abbreviations
15.4. Disclaimer
15.5. Contact Us